Literature DB >> 3790749

Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons.

J Frisell, U Glas, L Hellström, A Somell.   

Abstract

In March 1981 a randomized single-view mammographic screening for breast cancer was started in the south of Stockholm. The screened population in the first round numbered 40,318 women, and 20,000 women served as a well-defined control group. The age groups represented were 40-64 years, and 80.7% of the invited women participated in the study. The first round disclosed 128 breast cancers (113 invasive and 15 noninvasive), or 4.0 per 1,000 women. Mean tumour size was 14.1 mm and axillary lymph node metastases were found in 21.8%. Fifty-five per cent of the tumours were small (less than or equal to 10 mm) or non-invasive, and 71% were stage I. Participation rates are high in all Swedish trials. The present results differ only slightly from other screening programs; the percentages of patients with axillary metastases and stage II tumours are similar in the Stockholm, Malmö and Kopparberg/Ostergötland studies. Comparisons of cancer prevalence in the various Swedish screening trials show that, in comparable age groups, there are some differences, even when the differences in the natural cancer incidence are taken into account. A decreased mortality was found recently in a Swedish trial in ages above 50 years but not below. In the Stockholm study more than one-third of the participants were aged 40-49 years.

Entities:  

Mesh:

Year:  1986        PMID: 3790749     DOI: 10.1007/bf01805924

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  36 in total

1.  New technique for increasing the efficiency of self-examination in early diagnosis of breast cancer.

Authors:  G Gästrin
Journal:  Br Med J       Date:  1976-09-25

2.  Evidence on screening for breast cancer from a randomized trial.

Authors:  S Shapiro
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Periodic breast cancer screening in reducing mortality from breast cancer.

Authors:  S Shapiro; P Strax; L Venet
Journal:  JAMA       Date:  1971-03-15       Impact factor: 56.272

4.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

5.  Breast cancer screening in Malmö.

Authors:  I Andersson
Journal:  Recent Results Cancer Res       Date:  1984

6.  Five-year experience with single-view mammography randomized controlled screening in Sweden.

Authors:  L Tabár; E Akerlund; A Gad
Journal:  Recent Results Cancer Res       Date:  1984

7.  Increasing incidence and constant mortality rates of breast cancer: time trends in Stockholm County 1961-1973.

Authors:  L E Rutqvist
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

8.  Screening for breast cancer: the Swedish trial.

Authors:  L Tabàr; A Gad
Journal:  Radiology       Date:  1981-01       Impact factor: 11.105

Review 9.  Screening for breast cancer.

Authors:  A B Miller
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

10.  Trial of early detection of breast cancer: description of method.

Authors: 
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

View more
  19 in total

Review 1.  Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Authors:  J Ringash
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

Review 2.  Aneuploidy as a prognostic factor in breast cancer.

Authors:  A von Rosen
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.

Authors:  M Blichert-Toft; H P Graversen; J Andersen; U Dyreborg; A Green
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

4.  Visibility of mammographically occult breast cancer on diffusion-weighted MRI versus ultrasound.

Authors:  Nita Amornsiripanitch; Habib Rahbar; Averi E Kitsch; Diana L Lam; Brett Weitzel; Savannah C Partridge
Journal:  Clin Imaging       Date:  2017-10-28       Impact factor: 1.605

5.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

6.  The Stockholm breast cancer screening trial--5-year results and stage at discovery.

Authors:  J Frisell; G Eklund; L Hellström; U Glas; A Somell
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

Review 7.  [Radiological diagnosis of mammary carcinomas. I: pathology and x-ray mammography].

Authors:  R Schulz-Wendtland; H-P Sinn
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

8.  Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance.

Authors:  E Lidbrink; J Frisell; Y Brandberg; I Rosendahl; L E Rutqvist
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

9.  Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial.

Authors:  J Frisell; G Eklund; L Hellström; E Lidbrink; L E Rutqvist; A Somell
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

10.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.